1st Quarter - Report

AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS for AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS

Firm
Client
Income
—
Expenses
$240,223
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Immigration IMM

Immigration and womens health (general); Health care work force (general); Abortion (general); Pregnant women in immigration detention;

LobbyistCovered position, as disclosed
TATIANA CALDERON —
EMILY ECKERT New —
LISA SATTERFIELD New —
RACHEL TETLOW —
MEREDITH YINGER New —

Contacted: Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); State, Dept of (DOS); Agency for Healthcare Research & Quality (AHRQ); SENATE; Office of Management & Budget (OMB); Homeland Security, Dept of (DHS); Defense, Dept of (DOD); Justice, Dept of (DOJ); Labor, Dept of (DOL); Substance Abuse & Mental Health Services Administration (SAMHSA); Health & Human Services, Dept of (HHS); Office of Natl Drug Control Policy (NDCP); Indian Health Service; HOUSE OF REPRESENTATIVES; White House Office; Small Business Administration (SBA); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); Veterans Affairs, Dept of (VA); U.S. Agency for International Development (USAID)

Government Issues GOV

Family planning (general); Maternal health (general).

LobbyistCovered position, as disclosed
TATIANA CALDERON —
EMILY ECKERT New —
LISA SATTERFIELD New —
RACHEL TETLOW —
MEREDITH YINGER New —

Contacted: Small Business Administration (SBA); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); Centers For Disease Control & Prevention (CDC); SENATE; Labor, Dept of (DOL); Veterans Affairs, Dept of (VA); Agency for Healthcare Research & Quality (AHRQ); Executive Office of the President (EOP); Justice, Dept of (DOJ); Substance Abuse & Mental Health Services Administration (SAMHSA); Food & Drug Administration (FDA); White House Office; Natl Institutes of Health (NIH); Office of Management & Budget (OMB); Indian Health Service; Homeland Security, Dept of (DHS); State, Dept of (DOS); U.S. Agency for International Development (USAID); Defense, Dept of (DOD); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

Health Insurance Coverage (general); Health Disparities (general); Breastfeeding (general); Assisted Reproductive Technology (general); Smoking Cessation (general); Substance Use Disorder (general); Gynecologic Cancer (general); Gynecologic Devices (general); Reproductive Health (general); Intimate Partner Violence (general); Gun Violence (general); Immunization (general); Breast Cancer (general); E-Cigarettes (general); Medical Liability Reform (general); Health IT (general); Patient-Physician Relationship (general); Conscience Refusals (general); Child Welfare (general); Prematurity (general); Maternal Mortality and Morbidity (general); Graduate Medical Education (general); Contraception (general); Abortion (general); Indian Health (general); Teaching Health Centers Graduate Medical Education (general); Community Health Centers (general); National Health Service Corps (general); Special Diabetes Program (general); Special Diabetes Program for Indians (general); Sexuality Education (general); Teen Pregnancy Prevention Program (general); Personal Responsibility Education Program (general); Research in Pregnant and Breastfeeding Women (general); Health Care Reform (general); Title X Family Planning Program (general); Womens Preventive Services (general); Drug Pricing (general); Administrative Burden (general); Surprise Billing (general); Pediatric Loan Repayment Program (general); S. 130/S. 311, Born-Alive Abortion Survivors Protection Act; H.R. 2975/S. 1645, Womens Health Protection Act;; S. 1895, Lower Health Care Costs Act; H.R. 2862/S. 1619, VACCINES Act; implementation of P.L. 115-344, Preventing Maternal Deaths Act; implementation of P.L. 115-320, Improving Access to Maternity Care Act; S. 2586, Maternal Outcomes Matter Act; HR 3630, No Surprises Act; HR 3502, Protecting People From Surprise Medical Bills Act; Cures 2.0; H.R. 4495, Maternal Health Quality Improvement Act of 2019; H.R. 4996, Helping MOMS Act; H.R. 5640/S. 3152, the Data Mapping to Save Moms Lives Act; H.R. 6142/ S. 3424, the Black Maternal Health Momnibus Act of 2020; H.R. 6159, Kids Access to Primary Care Act of 2020; H.R.6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748/ S. 3548, the Coronavirus Aid, Relief, and Economic Security Act.

LobbyistCovered position, as disclosed
TATIANA CALDERON —
EMILY ECKERT New —
LISA SATTERFIELD New —
RACHEL TETLOW —
MEREDITH YINGER New —

Contacted: Health Resources & Services Administration (HRSA); White House Office; Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); Office of Management & Budget (OMB); Agency for Healthcare Research & Quality (AHRQ); Small Business Administration (SBA); Natl Institutes of Health (NIH); State, Dept of (DOS); SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); Centers For Disease Control & Prevention (CDC); Executive Office of the President (EOP); Homeland Security, Dept of (DHS); Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS); U.S. Agency for International Development (USAID); Food & Drug Administration (FDA); Indian Health Service; Veterans Affairs, Dept of (VA); Office of Natl Drug Control Policy (NDCP); Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES

Bills named: H.R. 6159 (116th), H.R. 3502 (116th), S. 2586 (116th), S. 1895 (116th), S. 3152 (116th), H.R. 5640 (116th), H.R. 4996 (116th), S. 1619 (116th), H.R. 2862 (116th), H.R. 6201 (116th), H.R. 6074 (116th), H.R. 2975 (116th), H.R. 3630 (116th), S. 3424 (116th), S. 311 (116th), S. 130 (116th), S. 1645 (116th), H.R. 748 (116th), H.R. 4495 (116th), H.R. 6142 (116th), S. 3548 (116th)

Medicare/Medicaid MMM

Childrens Health Insurance Program (CHIP); Implementation of P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015; Medicaid (general); Medicare (general); Telemedicine reimbursement (general); Medicare reimbursement (general); Health Care Reform (general); Medicaid DSH Payments (general); CY2021 Physician Fee Schedule E/M globals.

LobbyistCovered position, as disclosed
TATIANA CALDERON —
EMILY ECKERT New —
LISA SATTERFIELD New —
RACHEL TETLOW —
MEREDITH YINGER New —

Contacted: Agency for Healthcare Research & Quality (AHRQ); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH); Small Business Administration (SBA); White House Office; Executive Office of the President (EOP); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); U.S. Agency for International Development (USAID); Veterans Affairs, Dept of (VA); Health Resources & Services Administration (HRSA); Substance Abuse & Mental Health Services Administration (SAMHSA); State, Dept of (DOS); Office of Natl Drug Control Policy (NDCP); Justice, Dept of (DOJ); Indian Health Service; Labor, Dept of (DOL); Homeland Security, Dept of (DHS); Centers For Disease Control & Prevention (CDC)

Budget/Appropriations BUD

Funding for National Institutes of Health (NIH); Health Resources and Services Administration (HRSA); Centers for Disease Control and Prevention (CDC); Agency for Healthcare Research and Quality (AHRQ); American Indian/Alaska Native Womens Health (IHS); International Family Planning; Health Disparities (HHS); Safe Motherhood (CDC); Global Maternal and Child Health (USAID); Maternal Morbidity and Mortality (CDC, HRSA); Maternal Therapeutics Research and Regulation (HHS, NIH, FDA); Reproductive Health (general); Womens Health Research (NIH); Gun Violence Research (CDC); HIV Prevention (DASH); Medicaid and Medicare (CMS); Division of Reproductive Health (CDC); Pregnancy Risk Assessment Monitoring System (CDC); National Center on Birth Defects and Developmental Disabilities (CDC); National Center for Environmental Health (CDC); Public Health Surveillance (general); National Health Service Corps (HRSA); Substance Use Disorder Treatment (SAMHSA); Office on Smoking and Health (CDC); Title V Block Grant (HRSA); Title X Family Planning Program (OPA); Teen Pregnancy Prevention Program (OAH); Screening and Treatment for Maternal Depression (HHS); Endometriosis (NIH, CDC); Center for Primary Care Research (AHRQ); public health surveillance (CDC); WIC Breastfeeding Peer Counselor Program (Ag); Research in Pregnant and Breastfeeding Women (general); H.R.___/S.___ Fiscal Year 2021 Labor, Health and Human Services, Education Appropriations Act.

LobbyistCovered position, as disclosed
TATIANA CALDERON —
EMILY ECKERT New —
LISA SATTERFIELD New —
RACHEL TETLOW —
MEREDITH YINGER New —

Contacted: Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Small Business Administration (SBA); Labor, Dept of (DOL); Agency for Healthcare Research & Quality (AHRQ); Office of Natl Drug Control Policy (NDCP); Justice, Dept of (DOJ); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Centers For Disease Control & Prevention (CDC); U.S. Agency for International Development (USAID); White House Office; Veterans Affairs, Dept of (VA); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Substance Abuse & Mental Health Services Administration (SAMHSA); SENATE; Defense, Dept of (DOD); Indian Health Service; Homeland Security, Dept of (DHS); Executive Office of the President (EOP)

Veterans VET

Womens Health Research (general); Assisted Reproductive Technology (general); Gender based health services (general); Provider scope of practice (general); Military Sexual Trauma (general); Abortion (general)

LobbyistCovered position, as disclosed
TATIANA CALDERON —
EMILY ECKERT New —
LISA SATTERFIELD New —
RACHEL TETLOW —
MEREDITH YINGER New —

Contacted: Agency for Healthcare Research & Quality (AHRQ); White House Office; Veterans Affairs, Dept of (VA); Justice, Dept of (DOJ); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Substance Abuse & Mental Health Services Administration (SAMHSA); Labor, Dept of (DOL); Defense, Dept of (DOD); Health Resources & Services Administration (HRSA); U.S. Agency for International Development (USAID); Office of Natl Drug Control Policy (NDCP); Centers For Disease Control & Prevention (CDC); SENATE; Natl Institutes of Health (NIH); Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); State, Dept of (DOS); Food & Drug Administration (FDA); Indian Health Service; Small Business Administration (SBA)

Small Business SMB

Paycheck Protection Program (general), Direct financial assistance for physicians (general)

LobbyistCovered position, as disclosed
TATIANA CALDERON —
EMILY ECKERT New —
LISA SATTERFIELD New —
RACHEL TETLOW —
MEREDITH YINGER New —

Contacted: Food & Drug Administration (FDA); White House Office; Justice, Dept of (DOJ); Labor, Dept of (DOL); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); Office of Natl Drug Control Policy (NDCP); Agency for Healthcare Research & Quality (AHRQ); Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); U.S. Agency for International Development (USAID); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Substance Abuse & Mental Health Services Administration (SAMHSA); Veterans Affairs, Dept of (VA); Centers For Disease Control & Prevention (CDC); Executive Office of the President (EOP); Defense, Dept of (DOD); Indian Health Service; Small Business Administration (SBA); Natl Institutes of Health (NIH); Homeland Security, Dept of (DHS)

Defense DEF

Congressionally Directed Medical Research Programs (CDMRP); Ovarian cancer research (general); Gynecologic cancer (general); Contraception Access (general); Emergency Contraception (general); Military Sexual Trauma (general); Military Womens Health (general); Maternal Mortality and Morbidity (general); Postpartum care (general); Assisted Reproductive Technology (general); H.R. 2091/S. 1049, Access to Contraception for Women Servicemembers and Dependents Act; H.R. ___/S. ___National Defense Authorization Act for Fiscal Year 2021

LobbyistCovered position, as disclosed
TATIANA CALDERON —
EMILY ECKERT New —
LISA SATTERFIELD New —
RACHEL TETLOW —
MEREDITH YINGER New —

Contacted: Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Veterans Affairs, Dept of (VA); Agency for Healthcare Research & Quality (AHRQ); Substance Abuse & Mental Health Services Administration (SAMHSA); State, Dept of (DOS); White House Office; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); SENATE; Homeland Security, Dept of (DHS); Defense, Dept of (DOD); Food & Drug Administration (FDA); Small Business Administration (SBA); Office of Natl Drug Control Policy (NDCP); Indian Health Service; Justice, Dept of (DOJ); U.S. Agency for International Development (USAID); Natl Institutes of Health (NIH); Office of Management & Budget (OMB); Labor, Dept of (DOL)

Bills named: H.R. 2091 (116th), S. 1049 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.